Subscribe to our press releases
ChromoGenics is part of the EU’s Horizon 2020 project, NewSkin
ChromoGenics is one of the participants in a consortium around the EU project, NewSkin. The project will last for four years and ChromoGenic’s part in the project has a contribution of over SEK 2 million.
The NewSkin project aims to create what is called an “Open Innovation Test Bed (OITB)” to develop new nano-materials for both industrial and consumer products. The project is expected to last for four years.
For ChromoGenic’s part, the NewSkin project will use the company’s newly acquired and for Northern Europe completely unique sputtering capabilities to produce various new materials. It also provides an opportunity for ChromoGenics to develop materials that may be used in the company’s own innovative electrochromic products.
“The fact that ChromoGenics will be able to participate in NewSkin with our new sputters is a very big step for the new factory, and ChromoGenics will directly benefit technically from the project’s results in our own future products.” says CTO Greger Gregard.
Jerker Lundgren, VD
Lars Ericsson, CFO & Kommunikationschef
Tel: +46 (0)18 430 0430
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser e-mail: firstname.lastname@example.org, tel: +46 (0) 8 463 83 00.